Lung Cancer Resection Linked to Longer Survival for Older Patients

This article originally appeared here.
Share this content:
Lung Cancer Resection Linked to Longer Survival for Older Patients
Lung Cancer Resection Linked to Longer Survival for Older Patients

THURSDAY, May 5, 2016 (HealthDay News) -- Older lung cancer patients are surviving longer when they have lung cancer surgery, according to a study published online May 5 in the Annals of Thoracic Surgery.

"This greater than expected survival in older patients selected for operative therapy is noteworthy, especially considering that the prevalence of lung cancer is expected to increase as the population continues to grow older and more people survive into old age," study author Felix Fernandez, M.D., from Emory Clinic in Atlanta, said in a journal news release. The median age of U.S. lung cancer patients at the time of diagnosis is 70, according to the American Cancer Society. About 17 percent of all patients diagnosed with lung cancer live for at least five years, according to the U.S. National Cancer Institute.

In the study, researchers examined data from tens of thousands of patients aged 65 and older who had lung cancer surgery in the United States between 2002 and 2012. Median survival after surgery for early stage lung cancer was 6.7 years -- nearly two years longer than the benchmark five-year survival rate. The analysis also showed that five-year survival rates for certain older patients with advanced lung cancer who had surgery were 30 percent for stage III cancer and 27 percent for stage IV cancer.

The findings offer more information about survival after surgery, "which is important to patients. This information can be included in the shared decision-making process when discussing treatment options with patients," Fernandez said.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths